Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: Applications to AD, MCI, and normal aging

The ability to pool data from multiple MRI scanners is becoming increasingly important with the influx in multi-site research studies. Fast spin echo (FSE) dual spin echo sequences are often chosen for such studies based principally on their short acquisition time and the clinically useful contrasts they provide for assessing gross pathology. The practicality of measuring FSE-T2 relaxation properties has rarely been assessed. Here, FSE-T2 relaxation properties are examined across the three main scanner vendors (General Electric (GE), Philips, and Siemens). The American College of Radiology (ACR) phantom was scanned on four 1.5T platforms (two GE, one Philips, and one Siemens) to determine if the dual echo pulse sequence is susceptible to vendor-based variance. In addition, data from 85 subjects spanning the spectrum of normal aging, mild cognitive impairment (MCI), and Alzheimer's disease (AD) was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to affirm the presence of any phantom based between vendor variance and determine the relationship between this variance and disease. FSE-T2 relaxation properties, including peak FSE-T2 and histogram width, were calculated for each phantom and human subject. Direct correspondence was found between the phantom and human subject data. Peak FSE-T2 of Siemens scanners was consistently at least 20ms prolonged compared to GE and Philips. Siemens scanners showed broader FSE-T2 histograms than the other scanners. Greater variance was observed across GE scanners than either Philips or Siemens. FSE-T2 differences were much greater with scanner vendor than between diagnostic groups, as no significant changes in peak FSE-T2 or histogram width between normal aged, MCI, and AD subject groups were observed. These results indicate that whole brain histogram measures are not sensitive enough to detect FSE-T2 changes between normal aging, MCI, and AD and that FSE-T2 is highly variable across scanner vendors.

[1]  Reeti Tandon,et al.  High-field Magnetic Resonance Imaging of Brain Iron in Alzheimer Disease , 2006, Topics in magnetic resonance imaging : TMRI.

[2]  John Suckling,et al.  Standardized structural magnetic resonance imaging in multicentre studies using quantitative T 1 and T 2 imaging at 1.5 T , 2008, NeuroImage.

[3]  Kathryn Lunetta,et al.  Magnetic Resonance Imaging Traits in Siblings Discordant for Alzheimer Disease , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  A Brun,et al.  CORRELATIONS BETWEEN HISTOPATHOLOGIC WHITE MATTER CHANGES AND PROTON MR RELAXATION TIMES IN DEMENTIA , 1987, Alzheimer disease and associated disorders.

[5]  R. Martins,et al.  Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. , 2006, AJNR. American journal of neuroradiology.

[6]  G. Bartzokis,et al.  MR evaluation of age-related increase of brain iron in young adult and older normal males. , 1997, Magnetic resonance imaging.

[7]  B. Mädler,et al.  Insights into brain microstructure from the T2 distribution. , 2006, Magnetic resonance imaging.

[8]  Gaby S Pell,et al.  Voxel-based relaxometry: a new approach for analysis of T2 relaxometry changes in epilepsy , 2004, NeuroImage.

[9]  Osamu Sakai,et al.  Multispectral Quantitative Magnetic Resonance Imaging of Brain Iron Stores: A Theoretical Perspective , 2006, Topics in magnetic resonance imaging : TMRI.

[10]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[11]  Paul M. Thompson,et al.  White matter abnormalities in autism detected through transverse relaxation time imaging , 2006, NeuroImage.

[12]  D. Louis Collins,et al.  Automated Analysis of Multi Site MRI Phantom Data for the NIHPD Project , 2006, MICCAI.

[13]  J. Gore,et al.  Errors in the measurements of T2 using multiple‐echo MRI techniques. II. Effects of static field inhomogeneity , 1986, Magnetic resonance in medicine.

[14]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[15]  John D. Carew,et al.  Investigating the Medial Temporal Lobe in Alzheimer’s Disease and Mild Cognitive Impairment, with Turboprop Diffusion Tensor Imaging, MRI-volumetry, and T2-relaxometry , 2007, Brain Imaging and Behavior.

[16]  David Katz,et al.  The relation between brain iron and NMR relaxation times: An in vitro study , 1996, Magnetic resonance in medicine.

[17]  A. Mackay,et al.  In vivo measurement of T2 distributions and water contents in normal human brain , 1997, Magnetic resonance in medicine.

[18]  Karsten Specht,et al.  Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry , 2005, NeuroImage.

[19]  K. Krishnan,et al.  Quantitative analysis of T2 signal intensities in Alzheimer's Disease , 1998, Psychiatry Research: Neuroimaging.

[20]  J C Gore,et al.  Errors in the measurements of T2 using multiple‐echo MRI techniques. I. Effects of radiofrequency pulse imperfections , 1986, Magnetic resonance in medicine.

[21]  Shelton D. Caruthers,et al.  Quantitative Magnetic Resonance Imaging With The Mixed Turbo Spin-echo Pulse Sequence: A Validation Study , 2000 .

[22]  John Breitner,et al.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.

[23]  T. Ihalainen,et al.  MRI quality control: six imagers studied using eleven unified image quality parameters , 2004, European Radiology.

[24]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[25]  H. Soininen,et al.  Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease , 1996, Neurology.

[26]  Clifford R. Jack,et al.  Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease , 2008, NeuroImage.

[27]  B. Reisberg,et al.  Global Deterioration Scale (GDS). , 1988, Psychopharmacology bulletin.

[28]  B. Reisberg,et al.  The GDS/FAST Staging System , 1997, International Psychogeriatrics.

[29]  C. S. Poon,et al.  Practical T2 quantitation for clinical applications , 1992, Journal of magnetic resonance imaging : JMRI.

[30]  Huali Wang,et al.  Prolongation of T2 relaxation times of hippocampus and amygdala in Alzheimer's disease , 2004, Neuroscience Letters.

[31]  Karsten Specht,et al.  Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy—A comparison between clinical subtypes and correlations with clinical parameters , 2007, NeuroImage.

[32]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[33]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[34]  Larry L. Butcher,et al.  Prolongation of magnetic resonance T 2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease , 1992, Neuroscience Letters.

[35]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[36]  C R Jack,et al.  Hippocampal T2 relaxometry in epilepsy: past, present, and future. , 1996, AJNR. American journal of neuroradiology.

[37]  Graeme D. Jackson,et al.  Composite voxel-based analysis of volume and T2 relaxometry in temporal lobe epilepsy , 2008, NeuroImage.

[38]  Osamu Sakai,et al.  Combined volumetric T1, T2 and secular-T2 quantitative MRI of the brain: age-related global changes (preliminary results). , 2006, Magnetic resonance imaging.

[39]  H. Soininen,et al.  MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment , 1996, Neurobiology of Aging.